RIMAG GROUP (02522) spent 1.996 million Hong Kong dollars on December 10 to repurchase 194,000 shares.
Sun Ray (02522) announced that on December 10, 2025, it spent 1.996 million Hong Kong dollars to repurchase 194,000 shares.
RIMAG GROUP (02522) announced on December 10, 2025, it will spend HK$1,996,000 to repurchase 194,000 shares.
Related Articles
Director Ma Hongfu of Lanzhou Zhuangyuan Pasture (002910.SZ) plans to reduce his shareholding by no more than 3%.
C.Q. Pharmaceutical Holding (000950.SZ), a shareholder of Drug Friend Pharmaceutical, signed a licensing agreement with Pfizer.
GUOFUHEE (02582) plans to repurchase H shares.
Director Ma Hongfu of Lanzhou Zhuangyuan Pasture (002910.SZ) plans to reduce his shareholding by no more than 3%.
C.Q. Pharmaceutical Holding (000950.SZ), a shareholder of Drug Friend Pharmaceutical, signed a licensing agreement with Pfizer.
GUOFUHEE (02582) plans to repurchase H shares.
RECOMMEND
McDonald’s to Evaluate Franchisee Pricing for Customer Value Under Revised Standards
10/12/2025
Baidu’s AI Ace Kunlunxin Prepares For Hong Kong IPO, Domestic Computing Power Faces Crucial Test
08/12/2025
Institutions Say Short-Term Volatility Does Not Alter Upward Trend Of Hong Kong Stocks, Hang Seng Index Still Expected To Challenge 30,000 Points Next Year
08/12/2025
